Evidence map›Paper›PMID 26030592›Full record

ArticlePloS one2015

Theoretical Insights Reveal Novel Motions in Csk's SH3 Domain That Control Kinase Activation.

Sulyman Barkho, Levi C T Pierce, Sheng Li, Joseph A Adams, Patricia A Jennings

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sulyman BarkhoDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, California, United States of America.
Levi C T PierceDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, California, United States of America.
Sheng LiDepartment of Medicine, University of California San Diego, La Jolla, California, United States of America.
Joseph A AdamsDepartment of Pharmacology, University of California San Diego, La Jolla, California, United States of America.
Patricia A JenningsDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, California, United States of America.
University of California, San Diego · US

Funding

MOLECULAR BIOPHYSICS TRAINING PROGRAMT32GM008326 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOMIVES, ELIZABETH A. · 1989 to 2020
$7.5M
ACTION OF LIPOLYTIC ENZYMESR01GM020501 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DENNIS, EDWARD A · 1985 to 2020
$7.3M
Role of protein phosphorylation in RNA splicingR01GM067969 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADAMS, JOSEPH · 2004 to 2024
$6.4M
Mechanism of receptor-mediated entry and infection by filovirusesR01AI101436 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CHANDRAN, KARTIK · 2012 to 2016
$4.0M
STRUCTURE DRIVEN ANALYSIS OF EBOLA VIRUS RECEPTOR BINDING SITER01AI081982 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI SAPHIRE, ERICA OLLMANN · 2010 to 2014
$2.8M
Clk Kinases and Splicing RegulationR01GM098528 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADAMS, JOSEPH · 2012 to 2019
$2.5M
The New Family of NEET Proteins: 2Fe-2S Protein Mediated Health and DiseaseR01GM101467 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JENNINGS, PATRICIA A · 2012 to 2015
$1.3M
DESIGN OF AMPHIPHILIC PEPTOID ASSEMBLIESF32GM020501 · NIGMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BURKOTH, TIMOTHY S · 2000 to 2002
$75k
NIAID NIH HHS AI081982NIAID NIH HHS AI101436NIAID NIH HHS R01 AI081982NIAID NIH HHS R01 AI101436NIGMS NIH HHS F32 GM020501NIGMS NIH HHS GM020501NIGMS NIH HHS GM067969NIGMS NIH HHS GM098528NIGMS NIH HHS GM101467NIGMS NIH HHS R01 GM020501NIGMS NIH HHS R01 GM101467NIGMS NIH HHS T32 GM008326
6 · The paper itself

Abstract

The Src family of tyrosine kinases (SFKs) regulate numerous aspects of cell growth and differentiation and are under the principal control of the C-terminal Src Kinase (Csk). Although Csk and SFKs share conserved kinase, SH2 and SH3 domains, they differ considerably in three-dimensional structure, regulatory mechanism, and the intrinsic kinase activities. Although the SH2 and SH3 domains are known to up- or down-regulate tyrosine kinase function, little is known about the global motions in the full-length kinase that govern these catalytic variations. We use a combination of accelerated Molecular Dynamics (aMD) simulations and experimental methods to provide a new view of functional motions in the Csk scaffold. These computational studies suggest that high frequency vibrations in the SH2 domain are coupled through the N-terminal lobe of the kinase domain to motions in the SH3 domain. The effects of these reflexive movements on the kinase domain can be viewed using both Deuterium Exchange Mass Spectrometry (DXMS) and steady-state kinetic methods. Removal of several contacts, including a crystallographically unobserved N-terminal segment, between the SH3 and kinase domains short-circuit these coupled motions leading to reduced catalytic efficiency and stability of N-lobe motifs within the kinase domain. The data expands the model of Csk's activation whereby separate domains productively interact with two diametrically opposed surfaces of the kinase domain. Such reversible transitions may organize the active structure of the tyrosine kinase domain of Csk.

Indexed as

Models, MolecularMotionsrc Homology DomainsBiocatalysisCSK Tyrosine-Protein KinaseDeuterium Exchange MeasurementEnzyme ActivationKineticsMass SpectrometryMolecular Dynamics SimulationSolventssrc-Family KinasesTime FactorsCSK Tyrosine-Protein KinaseSolventssrc-Family Kinases

Identifiers

PMID26030592
PMCPMC4452171
OpenAlexW646881111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.